Panagora Asset Management’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
Panagora Asset Management's INZY Position: Q3 2025 in Review
Panagora Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 15,166 shares — an estimated $60.7K sold.
Panagora Asset Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $60.7K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.
- Panagora Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
- Panagora Asset Management sold 15,166 Inozyme Pharma shares in Q3 2025, an estimated $60.7K.
- Panagora Asset Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
- Panagora Asset Management's Inozyme Pharma position peaked at $60.7K in Q2 2025.
- 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.
Based on Panagora Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.